Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study
Jian Li(Beijing Normal University), Lin Shen(Peking University), Yanhong Deng(Sun Yat-sen University), Shirong Cai(Sun Yat-sen University), Wenxiao Ren, Yuehong Cui, Jiren Yu(Hangzhou First People's Hospital), Zhichao Zheng(Liaoning Cancer Hospital & Institute), Yongjian Zhou(First Affiliated Hospital of Zhengzhou University), Kaixiong Tao(Union Hospital), Kuntang Shen(Sun Yat-sen University), Hui Cao(Huainan Normal University), Xinhua Zhang(Nantong University), Wei Wang(Air Force Medical University), Jun Zhang(Army Medical University), Jason Yang, Jin Hu(First Affiliated Hospital of GuangXi Medical University), Xin Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wanqi Zhao, Ye Zhou(Second Military Medical University), Yanqiao Zhang(Harbin Medical University), Chenglin Qu
Cited by 14
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Systemic immune-inflammation index for predicting prognosis of colorectal cancer
|World Journal of Gastroenterology|2017|736
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
|JNCI Journal of the National Cancer Institute|1999|558